Journal Logo

About the Journal

Published bi-monthly, ASAM’s peer-reviewed Journal promotes excellence in the practice of addiction medicine and in clinical research, supporting addiction medicine as a mainstream medical sub-specialty. The Journal is published for physicians and other health professionals who need the most current news and information related to treatment of addiction disorders information. Under the guidance of an esteemed Editorial Board, Journal of Addiction Medicine’s peer-reviewed articles focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics. Each issue of the journal offers CME/MOC opportunities. The Journal is currently ranked in the Substance Abuse category of the Journal Citation Reports' Web Science Citation Index (SCI).  
 
JAM is read by one of the largest addiction-specialty physician readerships on the globe: ASAM members as well as their professional colleagues. Additionally, JAM was accepted for citation in June 2011 by the National Library of Medicine. This development facilitates increased dissemination of content and has since been augmented with significantly expanded pagination. Since inception, JAM has been cited by peer-reviewed global search engines, including PubMed/NLM, BIOSIS Previews, PsychINFO, Ebsco A-Z, CNKI – The China National Knowledge Infrastructure, ProQuest Summons, Sage Knowledge, SWETS, TDNet, and Journal Guide.​

Topics covered in the journal: 

•addiction and substance use in pregnancy

•adolescent addiction and at-risk use

•the drug-exposed neonate

•pharmacology

•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances

•diagnosis

•neuroimaging techniques

•treatment of special populations

•treatment, early intervention and prevention of alcohol and drug use disorders

•methodological issues in addiction research

•pain and addiction, prescription drug use disorder

•co-occurring addiction, medical and psychiatric disorders

•pathological gambling disorder, sexual and other behavioral addictions

•pathophysiology of addiction

•behavioral and pharmacological treatments

•issues in graduate medical education

•recovery

•health services delivery

•ethical, legal and liability issues in addiction medicine practice

•drug testing

•self- and mutual-help​

Publication & Editorial Staff Contacts

 


Associate Publisher
John Henry Scott

Director, Journal Publishing
Beth Guthy 
[email protected] 


Production Editor
Alicia Wallace 

 

Marketing Manager
Danielle Beren
[email protected]

 

Advertising Sales
Linda Barta
(678) 560-2810 | [email protected]

 

For Translation approval, License to republish and distribute,

or Permission to reuse material in another publication or presentation, please email one of the following:
[email protected]
[email protected]
[email protected]

 

LWW Business Offices
Two Commerce Square
2001 Market Street
Philadelphia, PA 19103
Phone:  215-521-8300
www.lww.com

 

Editor-in-Chief  (Acting) 
Frank J. Vocci, PhD

Co-Editors 

Kelly E. Dunn, PhD

Ismene Petrakis, MD

Martha J. Wunsch, MD, FAAP, DFASAM​

Statistical Editors
Debbie M. Cheng, Sc.D.
Boston University School of Public Health

Sara Lodi, PhD
Boston University School of Public Health​

Charles Maynard, PhD
University of Washington

Antover Tuliao, PhD
Texas Tech University

Managing Editor
Michael A. Arends
[email protected]

Founding Editors and First Edition
George Koob, PhD
Shannon C. Miller, MD, DFASAM, DFAPA  
Martha Wunsch, MD, DFASAM, FAAP 
Inaugural Edition: April 2007





Editor Biographies

  

Kelly Dunn, Ph.D. is an Associate Professor in the Behavioral Pharmacology Research Unit in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University. Her research interests include mechanisms underlying opioid use disorder and development of effective treatment strategies, comorbid conditions in persons with opioid use disorder, and opioid overdose. Her research also includes randomized controlled evaluations of medications for alcohol use disorder and tobacco use, as well as development of standardized outcome measures.


Ismene L. Petrakis, M.D. is an addiction psychiatrist, a Professor of Psychiatry at the Yale University School of Medicine and the Chief of Psychiatry and Mental Health Services at VA Connecticut Healthcare System.  She is also the Director of the Addiction Psychiatry Residency at Yale University School of Medicine and the principal investigator of a National Institute of Drug Abuse (NIDA-T32) training grant. She is certified by the American Board of Psychiatry and Neurology and Addiction Psychiatry.


Frank J. Vocci, PhD, is President and Senior Research Scientist of Friends Research Institute in Baltimore, Maryland. He has previously served as Director of the National Institute on Drug Abuse’s Division of Pharmacotherapies and Medical Consequences of Drug Abuse and is a Fellow and Past-President of The College on Problems of Drug Dependence.  His research interests include developing medications for treating nicotine and stimulant use disorder, developing new treamnts for opioid use disorder, and evaluating best practices for treatment of opiate users with criminal justice involvement.

Martha J. Wunsch, MD, FAAP, DFASAMis a pediatrician and addiction medicine physician with Kaiser Permanente of Northern California. She is program director of the Northern California Kaiser Addiction Medicine Fellowship and Director of the Addiction Medicine Consultation Liaison Service at San Leandro Kaiser Hospital. Dr. Wunsch is the president elect of the American College of Academic Addiction Medicine and a member of the Sub-Board of Addiction for the American Board of Preventive Medicine.